Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May;135(5):1125-31.
doi: 10.1016/j.jaci.2014.09.014. Epub 2014 Oct 30.

Anaphylaxis: Unique Aspects of Clinical Diagnosis and Management in Infants (Birth to Age 2 Years)


Anaphylaxis: Unique Aspects of Clinical Diagnosis and Management in Infants (Birth to Age 2 Years)

F Estelle R Simons et al. J Allergy Clin Immunol. .


In this rostrum we aim to increase awareness of anaphylaxis in infancy in order to improve clinical diagnosis, management, and prevention of recurrences. Anaphylaxis is increasingly reported in this age group. Foods are the most common triggers. Presentation typically involves the skin (generalized urticaria), the respiratory tract (cough, wheeze, stridor, and dyspnea), and/or the gastrointestinal tract (persistent vomiting). Tryptase levels are seldom increased because of infant anaphylaxis, although baseline tryptase levels can be increased in the first few months of life, reflecting mast cell burden in the developing immune system. The differential diagnosis of infant anaphylaxis includes consideration of age-unique entities, such as food protein-induced enterocolitis syndrome with acute presentation. Epinephrine (adrenaline) treatment is underused in health care and community settings. No epinephrine autoinjectors contain an optimal dose for infants weighing 10 kg or less. After treatment of an anaphylactic episode, follow-up with a physician, preferably an allergy/immunology specialist, is important for confirmation of anaphylaxis triggers and prevention of recurrences through avoidance of confirmed specific triggers. Natural desensitization to milk and egg can occur. Future research should include validation of the clinical criteria for anaphylaxis diagnosis in infants, prospective longitudinal monitoring of baseline serum tryptase levels in healthy and atopic infants during the first year of life, studies of infant comorbidities and cofactors that increase the risk of severe anaphylaxis, development of autoinjectors containing a 0.1-mg epinephrine dose suitable for infants, and inclusion of infants in prospective studies of immune modulation to prevent anaphylaxis recurrences.

Keywords: Infants (birth to 2 years); adrenaline; antihistamines; clinical criteria for diagnosis; epinephrine; epinephrine autoinjectors; food allergy; food protein–induced enterocolitis syndrome; natural desensitization; tryptase.

Similar articles

See all similar articles

Cited by 15 articles

  • Refractory Anaphylaxis: Data From the European Anaphylaxis Registry.
    Francuzik W, Dölle-Bierke S, Knop M, Scherer Hofmeier K, Cichocka-Jarosz E, García BE, Lang R, Maris I, Renaudin JM, Worm M. Francuzik W, et al. Front Immunol. 2019 Oct 18;10:2482. doi: 10.3389/fimmu.2019.02482. eCollection 2019. Front Immunol. 2019. PMID: 31749797 Free PMC article.
  • Infantile Anaphylaxis in Korea: a Multicenter Retrospective Case Study.
    Jeon YH, Lee S, Ahn K, Lee SY, Kim KW, Kim HH, Kim JH, Yum HY, Kim WK, Park YM, Song TW, Kim J, Lee YJ, Jang GC, Jeong K, Kim YH, Min TK, Pyun BY; Food Allergy and Atopic Dermatitis (FAAD) Study Group in the Korean Academy of Pediatric Allergy and Respiratory Disease. Jeon YH, et al. J Korean Med Sci. 2019 Apr 8;34(13):e106. doi: 10.3346/jkms.2019.34.e106. J Korean Med Sci. 2019. PMID: 30950251 Free PMC article.
  • Drug-induced anaphylaxis in children.
    Cardinale F, Amato D, Mastrototaro MF, Caffarelli C, Crisafulli G, Franceschini F, Liotti L, Caimmi S, Bottau P, Saretta F, Mori F, Bernardini R. Cardinale F, et al. Acta Biomed. 2019 Jan 30;90(3-S):30-35. doi: 10.23750/abm.v90i3-S.8172. Acta Biomed. 2019. PMID: 30830059 Free PMC article. Review.
  • A survey of anaphylaxis etiology and treatment.
    Ahanchian H, Behmanesh F, Azad FJ, Ansari E, Khoshkhui M, Farid R, Hassanpur Y, Kouzegaran S. Ahanchian H, et al. Med Gas Res. 2019 Jan 9;8(4):129-134. doi: 10.4103/2045-9912.248262. eCollection 2018 Oct-Dec. Med Gas Res. 2019. PMID: 30713664 Free PMC article. Retracted.
  • Underuse of epinephrine for the treatment of anaphylaxis: missed opportunities.
    Prince BT, Mikhail I, Stukus DR. Prince BT, et al. J Asthma Allergy. 2018 Jun 20;11:143-151. doi: 10.2147/JAA.S159400. eCollection 2018. J Asthma Allergy. 2018. PMID: 29950873 Free PMC article. Review.
See all "Cited by" articles

Publication types